There’s always something new and exciting going on at INTERPHEX. Check out our announcements for the very latest news.

Share This:

Judging Panel For New INTERPHEX Exhibitor Awards Announced

01/30/2015

NEW YORK, NY; January 29, 2015 – International Pharmaceutical Expo (INTERPHEX), the premier pharmaceutical and biopharmaceutical event dedicated to innovation, technology and knowledge, and sponsored by the Parenteral Drug Association (PDA), today announced the judges of the new INTERPHEX Exhibitor Awards.

“Along with our media sponsor, Pharmaceutical Processing, we are delighted to announce the judges for the INTERPHEX Exhibitor Awards which recognize cutting-edge technology and the outstanding efforts of companies that support pharma and biopharma development and manufacturing,” said Ed Several, Senior Vice President and General Manager, INTERPHEX. “Our judging panel is comprised of highly esteemed technical professionals who possess a depth of industry knowledge and expertise. Each member was hand selected for their dedication and commitment to development and manufacturing excellence.”

Michael Auerbach, Pharmaceutical Processing
For the past twenty-six years, Editor-in-Chief Mike Auerbach has covered the pharmaceutical industry for Pharmaceutical Processing . Mr. Auerbach is responsible for developing the editorial content for Pharmaceutical Processing's print, web and e-newsletter offerings. A frequent participant in industry events, he has moderated panel discussions presented during INTERPHEX, and live webcasts and webinars. During his career he has interviewed numerous pharmaceutical industry execs on the latest trends, technologies and strategies to produce and manufacture pharmaceuticals. Pharmaceutical Processing delivers must-have content to more than 28,000 publication subscribers, 22,000 e-newsletter recipients, and more than 50,000 unique website visitors monthly.

Angelo DePalma, PhD,Technical Writing
Angelo DePalma, Ph.D., has been a healthcare industry writer for twenty-five years. His articles have appeared in dozens of print and online publications. He has also ghost-written articles for leading pharmaceutical, biotechnology, and supplier companies. Dr. DePalma holds a Ph.D. in organic chemistry. Before starting his writing services business he was Senior Scientist at Schering-Plough.

Jo Anne Jacobs, R.Ph., Director, Technical Services, Drug Product, Cook Pharmica LLC
Jo Anne Jacobs has been in the pharmaceutical industry for over twenty years, having worked in academic and commercial settings. She began her career in the pharmaceutical industry doing formulation development and small scale manufacturing of solid dosage forms. Ms. Jacobs has extensive experience in the manufacture of parenteral products, and she has additional experience with dry blending, wet granulation, fluid bed drying, tablet coating, etc. At Cook Pharmica, she works closely with the business development, project management, process development and manufacturing operations to ensure the successful technical transfer of both clinical and commercial products. Ms. Jacobs is also a Registered Pharmacist with hospital and community pharmacy experience. She has been active in many industry associations, including PDA and the South Carolina Pharmaceutical Association over the course of her career.

Patrick Poisson, SVP Manufacturing and Chief Manufacturing Officer,
United Therapeutics Corp.
Patrick Poisson holds the position of SVP, Manufacturing and Chief Manufacturing Officer with United Therapeutics, a rapidly growing pharmaceutical company based in Silver Spring, MD, where he is responsible for overseeing the company’s cell culture, purification and sterile filling manufacturing operations. Prior to joining United Therapeutics Mr. Poisson was employed by Cardinal Health and Genentech where he held various positions of escalating responsibility in manufacturing and product development. In addition to his 23 years of professional experience, Mr. Poisson has been a frequent technical speaker at industry conferences, is the co-author of multiple aseptic processing research articles, and is a named inventor in three international patents. Mr. Poisson holds a B.Sc. from Michigan State University.

Kristie Grammatikos, Office of the CIO, Planning & Innovation, Merck & Co. Inc.
Kristie Grammatikos currently manages multiple projects including Merck’s Emerging Talent Rotational Program. In this role, she is responsible for recruiting top talent to the company and developing their leadership capabilities. With a strong background in process/project engineering and sigma methodology (Black Belt certified), she has had substantial experience evaluating single use storage/container systems and helped coauthor Merck’s guidelines around visible particulates. In a similar capacity, she utilized total cost of ownership models to evaluate the financial feasibility of single use components; the output of which was used to negotiate lower consumable prices and reduce process operating cost. Ms. Grammatikos’ work history includes projects in the United States, France, and Mexico and has focused on API manufacturing, sterile production, and vaccines/biologics processing. She holds a M.S. in Engineering Management and a B.S. in Chemical Engineering. She is certified as a Fire Fighter and Emergency Medical Technician and volunteers in her free time.

Gil Roth, Founder, President, Pharma & Biopharma Outsourcing Association
Gil Roth is the founder and president of the Pharma & Biopharma Outsourcing Association (PBOA), a nonprofit trade association for Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organizations (CDMO). In 1999, he helped launch Contract Pharma , which swiftly became the premier magazine covering the outsourcing and contract services industry. He served as editor from October 1999 until February 2014, chronicling the evolution of the pharmaceutical outsourcing sector. He also helped build Contract Pharma’s annual Contracting & Outsourcing Conference & Exhibition into a top-tier event for both contract service providers and their clients. In 2013, while reporting on an article about the Generic Drug User Fee Amendments (GDUFA), Mr. Roth had the idea to build a trade association (PBOA) for CMOs and CDMOs, in order to provide a voice in regulatory and legislative areas and to raise awareness of the pivotal role they play in healthcare. Gil Roth received a B.A. from Hampshire College and a M.A.L.A. from St. John’s College. He was an associate editor and managing editor for several business-to-business magazines before becoming the founding editor of Contract Pharma, a role he held for nearly 15 years.

David Hall, Vice President of Sales, Parenteral Drug Association
David Hall is currently the Vice President of Sales for the Parenteral Drug Association (PDA). He has more than twenty-five years of association, sales, and trade show management experience within the pharmaceutical and biotechnology industries with a core focus on customer relationship building and strategic alliances. Mr. Hall has consistently developed and implemented innovative strategies to drive revenue and increase sales from advertising, exhibition and event sponsorship sales while creating value for clients.

Winning exhibitors will be announced at INTERPHEX 2015 in New York, New York on April 21, 2015. A Call for Submissions for the INTERPHEX Exhibitor Awards has been issued and will be accepted through February 15, 2015. To submit or for additional details and criteria, please visit www.interphex.com/For-Exhibitors/Exhibitor-Award-Program/.

Note to Editors
The INTERPHEX Exhibitor Awards recognize cutting-edge technology and value-added solutions that enable biopharmaceutical development and manufacturing companies achieve business and production goals and objectives. Awards will be issued in the following categories: Best in Show, Honorable Mention, Best in Green Technology, Best New Product/Service, Editor’s Choice Award and Best Technologies Innovation. Winners are awarded for showcasing innovative technologies and/or new strategies and services that have significantly contributed to the industry.

About INTERPHEX
INTERPHEX (International Pharmaceutical Expo), sponsored by Parenteral Drug Association (PDA) is the single source for complete biopharmaceutical manufacturing solutions to safely and cost effectively process all dosage forms for life-enhancing drugs. It brings over 12,000 global pharmaceutical and biotechnology professionals together with 600+ suppliers via 300,000sf of event space through a unique combination of exhibition, education, workshops, partnering opportunities, and networking events. INTERPHEX offers annual national and international industry events and educational opportunities around the world.  For more information, visit www.INTERPHEX.com and follow INTERPHEX on Facebook, LinkedIn, Twitter and YouTubeIPX Blog continues the learning beyond the show floor and INTERPHEX Connector is the new twice-weekly email industry insight and news briefing.

About Pharmaceutical Processing
Since 1984 Pharmaceutical Processing has provided industry professionals with news and information on the cutting-edge technologies and services for the pharmaceutical, biopharmaceutical, nutraceutical, and medical device markets. Pharmaceutical Processing engages pharmaceutical and biopharmaceutical manufacturing professionals daily, weekly, and monthly with relevant industry news and technology solutions that solve critical issues, delivering it in the formats that meet their business and professional needs. From formulation to manufacturing to packaging, Pharmaceutical Processing provides comprehensive coverage on the latest technologies and best practices being used in today’s marketplace. Pharmaceutical Processing reaches more than 28,000 direct request publication subscribers, 24,000 e-newsletter recipients daily, and more than 40,000 unique website visitors monthly. www.PharmPro.com

About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of it’s nearly 10,000 members worldwide.

###

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.